A study found that liver resection dramatically enhances 5-year overall survival rates in T2 and T3 gallbladder cancer patients. Those undergoing this procedure had a survival rate of 43.8% versus 26.7% for non-surgical counterparts. Furthermore, achieving four or more lymph nodes increased survival to 49.9%. Radical resection notably improved survival to 52.5%. Subgroup analysis showed […]
Category: General Surgery
Pancreatic guidewire-assisted fistulotomy proves more effective
In a trial involving 194 patients facing difficult biliary cannulation, the pancreatic guidewire-assisted fistulotomy method achieved a significantly higher success rate of 93.8%, compared to 81.4% for the transpancreatic biliary sphincterotomy technique (p=0.01). Both techniques exhibited similar rates of adverse events, suggesting that fistulotomy is the preferred choice after failed cannulation attempts. The transpancreatic method […]
Reliable prediction model for anastomotic leakage in rectal cancer
A new clinical prediction model offers reliable assessment for anastomotic leakage (AL) in rectal cancer surgery, based on a study of 3,765 patients. The model identified key risk factors, including gender, diabetes, preoperative chemoradiotherapy, and surgical parameters. With area under the curve (AUC) values of 0.818 and 0.815 for internal validation, and consistent calibration results, […]
Different surgical options show varying effectiveness for GERD relief
A meta-analysis involving 9,516 patients found that all surgical procedures for gastroesophageal reflux disease (GERD) significantly improved post-operative outcomes. Nissen fundoplication outperformed transoral incisionless fundoplication in reducing acid exposure and Demeester scores. However, Toupet fundoplication and magnetic sphincter augmentation provided superior symptom relief compared to other methods. These insights enhance understanding of various surgical anti-reflux […]
Gastrointestinal motility agents improve recovery after colorectal surgery
Gastrointestinal motility agents significantly enhance recovery in patients after elective colorectal surgery, according to a systematic analysis of seven randomized controlled trials involving 849 individuals. Patients experienced accelerated gastrointestinal recovery by 1.01 days and reduced time to first bowel movement by 1.07 days. Importantly, safety outcomes, including rates of complications such as anastomotic leaks and […]
Key genes linked to colorectal cancer stemness identified
A recent study identified ten key genes associated with colorectal cancer (CRC) stemness, revealing their correlation with disease-free and progression-free survival. Using a machine learning model, researchers found that higher mRNA expression-based stemness indexes (mrnasi) correlated with improved clinical outcomes. Notably, CRC samples with lower mrnasi exhibited worse survival rates. This research highlights the potential […]
Nomogram predicts primary liver cancer risk in liver cyst patients
A newly developed nomogram effectively predicts the risk of primary liver cancer (PLC) in patients with liver cysts, integrating CT imaging features and alpha-fetoprotein (AFP) levels. In a study involving 122 participants, higher AFP levels and specific CT characteristics were linked to PLC occurrence. The nomogram exhibited a mean absolute error of 0.020 and achieved […]
Bariatric surgery improves liver health in MASLD patients
Current findings highlight the efficacy of bariatric surgery in treating metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to steatohepatitis. The surgical interventions, including Roux-en-Y gastric bypass and sleeve gastrectomy, significantly enhance liver outcomes by reducing steatosis, inflammation, and fibrosis, while lowering cancer risk. These improvements are linked to changes in liver transcriptional programs […]
New MRI Index Improves Risk Assessment for Liver Failure
A study involving 292 patients undergoing major liver surgery revealed that the hepatic uptake index (hui) derived from gadoxetic acid-enhanced MRI outperformed traditional volume-only assessments in identifying those at risk for severe post-hepatectomy liver failure (phlf). Among the cohort, 8.6% developed severe phlf, with affected individuals showing significantly lower hui scores. Combining hui with the […]
Mass-based drug screening shows promise for personalized chemotherapy
A phase II clinical trial demonstrates the feasibility of mass-based response testing (MRT) in tailoring intraperitoneal chemotherapy for patients with unresectable appendiceal or colorectal peritoneal metastases. MRT assessed tumor susceptibility to various HIPEC drug regimens, offering a personalized approach to treatment. The study aims to improve outcomes by personalizing regimens based on patient-specific sensitivities, thereby […]